Edition:
United States

Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

19.17USD
21 Sep 2018
Change (% chg)

$-0.51 (-2.59%)
Prev Close
$19.68
Open
$19.71
Day's High
$20.05
Day's Low
$18.97
Volume
509,072
Avg. Vol
168,985
52-wk High
$43.98
52-wk Low
$17.68

Chart for

About

Adamas Pharmaceuticals, Inc. is a pharmaceutical company. The Company is engaged in developing medicines to manage the daily lives of those affected by chronic neurologic disorders. It offers a platform based on an understanding of time dependent biologic effects of disease activity and drug response to achieve relief without... (more)

Overall

Beta: 1.36
Market Cap(Mil.): $521.24
Shares Outstanding(Mil.): 27.19
Dividend: --
Yield (%): --

Financials

  ADMS.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -4.92 -- --
ROI: -61.86 1.50 12.72
ROE: -98.74 0.19 14.85

BRIEF-Adamas Announces Final Results From Phase 3 Open-Label Study Of Gocovri

* ADAMAS ANNOUNCES FINAL RESULTS FROM THE TWO-YEAR PHASE 3 OPEN-LABEL STUDY OF GOCOVRI™ IN PARKINSON’S DISEASE PATIENTS WITH DYSKINESIA

Apr 19 2018

BRIEF-Adamas Announces First Patient Enrolled In Phase 3 Trial Of ADS 5102 In Multiple Sclerosis Patients With Walking Impairment

* 5102 IN MULTIPLE SCLEROSIS PATIENTS WITH WALKING IMPAIRMENT Source text for Eikon: Further company coverage:

Apr 03 2018

Earnings vs. Estimates